In recent years, QSP has emerged as a powerful research approach that enables scientific insight and informs early discovery to clinical development decisions. The most innovative R&D organizations in the industry are increasingly adopting QSP as an essential research component for more informed decision-making. ConstantiaRosa's participation in this workshop further demonstrates its commitment to expanding the adoption of QSP into a standard research method used within the pharmaceutical industry.
Dr. Christina Friedrich, Chief Engineer at Rosa, recently published an article on QSP model qualification, and participated in the workshop that brought together key opinion leaders from industry and academia to make a substantive contribution toward even broader implementation of QSP. The workshop capitalized on the group's accumulated experience and applications to review and discuss evolving methodologies in the field.